SAS Output

25-APR-2019 6:10

MMYEL ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1304-MM,relapsed/refractory, Car+Dex 1 N 1 Dex+Low Dose Carfilzomib 140 72 0 0 0 0 0 02/12/2014    
        2 Dex+High Dose Carfilzomib   71 0 0 0 0 0      
            143 0 0 0 0 0      
 
    2 Y 3 Dex+High Dose Carfilzomib 140 22 0 0 0 0 0 02/12/2014    
            22 0 0 0 0 0      
 
  S1702-AL Amyloidosis, Relapsed, Isatuximab 1 Y 1 Isatuximab 39 27 27 16 8 4 0 06/06/2018 164 60
            27 27 16 8 4 0      
 
Yes E1A11-MM, frontline, BLD vs CLD 1 E Total Registrations   259 62 27 1 0 0 03/05/2014   123
            259 62 27 1 0 0      
 
No A061402-Solitary Plasmacytoma, adj sys+Zol vs Zol 0 E Total Registrations   1 0 0 0 0 0 01/27/2017    
            1 0 0 0 0 0      
 
  E1A11-MM, frontline, BLD vs CLD 0 E Total Registrations   283 64 26 1 0 0 03/05/2014   123
            283 64 26 1 0 0      
 
    2 E Total Registrations   92 31 15 4 1 0 03/05/2014    
            92 31 15 4 1 0      
 

25-APR-2019 6:10

MMYEL Open Studies with No Registrations

The REPORT Procedure

Detailed and/or summarized report

Table 1

Study Registration/Phase Open Date
S1803 MM, Maintenance, Len vs Len/Dara 1 Study Entry 22-Apr-19